Genscript Biotech (HKSE:01548) Days Payable : 34.33 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genscript Biotech Days Payable?

Genscript Biotech's average Accounts Payable for the six months ended in Dec. 2023 was HK$314 Mil. Genscript Biotech's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$1,669 Mil. Hence, Genscript Biotech's Days Payable for the six months ended in Dec. 2023 was 34.33.

The historical rank and industry rank for Genscript Biotech's Days Payable or its related term are showing as below:

HKSE:01548' s Days Payable Range Over the Past 10 Years
Min: 32.06 Med: 47.17 Max: 56.55
Current: 38.42

During the past 10 years, Genscript Biotech's highest Days Payable was 56.55. The lowest was 32.06. And the median was 47.17.

HKSE:01548's Days Payable is ranked worse than
79.42% of 719 companies
in the Biotechnology industry
Industry Median: 147.29 vs HKSE:01548: 38.42

Genscript Biotech's Days Payable declined from Dec. 2022 (44.93) to Dec. 2023 (34.33). It may suggest that Genscript Biotech accelerated paying its suppliers.

Genscript Biotech Days Payable Historical Data

The historical data trend for Genscript Biotech's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech Days Payable Chart

Genscript Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

56.55

55.61

46.96

48.79

40.55

Genscript Biotech Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial														44.82	40.65	44.93	40.40	34.33

Competitive Comparison of Genscript Biotech's Days Payable

For the Biotechnology subindustry, Genscript Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genscript Biotech's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genscript Biotech's Days Payable distribution charts can be found below:

* The bar in red indicates where Genscript Biotech's Days Payable falls into.

Genscript Biotech Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Genscript Biotech's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (434.075	+	312.072)	/	2 )	/	3358.027	*	365
=	373.0735					/	3358.027	*	365
=	40.55

Genscript Biotech's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (315.889	+	312.072)	/	2 )	/	1669.056	*	365 / 2
=	313.9805					/	1669.056	*	365 / 2
=	34.33

Genscript Biotech Days Payable Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Genscript Biotech (HKSE:01548) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (HKSE:01548) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

GNNSF:USA G51:Germany

Address

No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100

Website

https://www.genscript.com

GenScript Biotech is a China-based provider of life science research services and products. Founded in 2002, it is best known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, it owns 57.1% of Nasdaq-listed Legend Biotech, whose key pipeline asset is a BCMA-targeting CAR-T treatment for multiple myeloma. We estimate that more than two thirds of GenScript's valuation is from its ownership stake in Legend.

Genscript Biotech (HKSE:01548) Headlines

No Headlines